Inhibition of factor IX(a) is protective in a rat model of thromboembolic stroke by TOOMEY, John R, VALOCIK, Richard E, KOSTER, Paul F, GABRIEL, Melanie A, MCVEY, Matt, HART, Timothy K, OHLSTEIN, Eliot H, PARSONS, Andrew A, BARONE, Frank C

Get full text

Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thr... by Toomey, John R, Blackburn, Michael N, Storer, Barbara L, Valocik, Richard E, Koster, Paul F, Feuerstein, Giora Z

Get full text

Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist by Bondinell, William E., Keenan, Richard M., Miller, William H., Ali, Fadia E., Allen, Andrew C., De Brosse, Charles W., Eggleston, Drake S., Erhard, Karl F., Haltiwanger, R.Curtis, Huffman, William F., Hwang, Shing-Mei, Jakas, Dalia R., Koster, Paul F., Ku, Thomas W., Lee, Chao Pin, Nichols, Andrew J., Ross, Stephen T., Samanen, James M., Valocik, Richard E., Vasko-Moser, Janice A., Venslavsky, Joseph W., Wong, Angela S., Yuan, Chuan-Kui

Get full text

Structure-activity relationships in 3-oxo-1,4-benzodiazepine-2-acetic acid GPIIb/IIIa antagonists. The 2-benzazepine series by Miller, William H., Ali, Fadia E., Bondinell, William E., Callahan, James F., Calvo, Raul R., Eggleston, Drake S., Curtis Haltiwanger, R., Huffman, William F., Hwang, Shing-Mei, Jakas, Dalia R., Keenan, Richard M., Koster, Paul F., Ku, Thomas W., Kwon, Chet, Newlander, Kenneth A., Nichols, Andrew J., Parker, Michael F., Samanen, James M., Southall, Linda S., Takata, Dennis T., Uzinskas, Irene N., Valocik, Richard E., Vasko-Moser, Janice A., Wong, Angela S., Yellin, Tobias O., Yuan, Catherine C.K.

Get full text